Clene (CLNN)
(Real Time Quote from BATS)
$0.39 USD
0.00 (-0.21%)
Updated May 14, 2024 11:08 AM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Price, Consensus and EPS Surprise
CLNN 0.39 0.00(-0.21%)
Will CLNN be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for CLNN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CLNN
Clene Inc. (CLNN) Reports Q1 Loss, Lags Revenue Estimates
Puma Biotech (PBYI) Reports Q1 Loss, Tops Revenue Estimates
CLNN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Clene Inc. (CLNN) Reports Q4 Loss, Tops Revenue Estimates
Dentsply International (XRAY) Q4 Earnings and Revenues Beat Estimates
Amicus Therapeutics (FOLD) Reports Q4 Loss, Lags Revenue Estimates
Other News for CLNN
Clene to Present at Upcoming May Conferences
Analysts Are Bullish on Top Healthcare Stocks: Regulus (RGLS), Zevra Therapeutics (ZVRA)
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
CLNN Stock Earnings: Clene Misses EPS, Misses Revenue for Q1 2024
Analysts Offer Insights on Healthcare Companies: PolyPid (PYPD) and Clene (CLNN)